Purpose: Lack of response to anti-epileptic drugs (AEDS) is considered a ''red flag'' pointing to a diagnosis of Psychogenic Nonepileptic Seizures (PNES). On the other hand, placebo effects are relevant in any medical condition with a complex psychosocial component. We aimed to evaluate the presence and frequency of a placebo response in patients with sole PNES and explore its impact on diagnostic delay. Methods: We reviewed the medical records of 102 patients referred for video EEG monitoring and diagnosed with PNES. Patients with PNES and epilepsy were excluded. The response to AEDs was analyzed according to patients' reports and medical records. Patients were classified, according to the response to AEDs, in two groups: responders (patients achieving remission) and non-responders. Then, we compared the diagnostic delay from the first event to the final diagnosis between these groups. Results: Forty-seven patients (79.7%) with sole PNES who were using AEDs were identified. Twenty-two patients (46.8%) had reported complete or partial remission of PNES with mean response duration of 7.2 months (SD + 9.6 months). The time delay of the diagnosis in the AED responder group was 10.6 years; the delay in non-responders was 5.6 years (p = 0.035). Conclusion: Patients with sole PNES receiving AEDs can go into PNES remission. A favorable response to AEDs is likely to be interpreted as supporting a diagnosis of epilepsy and is associated with diagnostic delay. Physicians should bear in mind that patients with PNES may be particularly vulnerable to placebo effects.
Introduction
The early and accurate recognition of Psychogenic Nonepileptic Seizures (PNES) and the differentiation of this disorder from epileptic seizures (ES) are of paramount importance. Extensive work has been conducted to identify the factors that might facilitate this diagnosis and consequent referral to video-EEG monitoring to decrease the delay in diagnosis. 1 Most patients with PNES are presumed to have epilepsy and are treated with anti-epileptic drugs (AEDs). 2, 3 A lack of response to AEDs is considered to be one of the most common ''red flags'' for screening for PNES and is among the main reasons for referral to tertiary epilepsy centers. 4 Placebo effects are significant in all medical disorders with a complex psychosocial component. 5, 6 Little published data exists regarding the placebo response to AED in PNES, but one study 7 suggested that placebo response occurs in 43% of all patients. This observational retrospective cohort study was conducted in a tertiary care center for epilepsy treatment and sought to accomplish the following: (i) document the presence and frequency of a placebo response characterized by a decrease in PNES following AED administration; and (ii) identify the possible effects of such decrease on diagnostic delay.
Methods

Patients
The studied population was selected from a consecutive series of 102 patients who were diagnosed with PNES. All patients were Patients with current or previous history of epilepsy were excluded. The criteria for the diagnosis of epilepsy were in agreement with previous work. 1, 6 We did not consider the following patients with PNES: (i) those without video-EEG confirmation, including patients with reliable home-videos or PNES that were witnessed by one of the authors and; (ii) those with unclear time of PNES onset. Thirty-five patients (34.3%) were excluded due to diagnoses of epilepsy and PNES, and nine (8.8%) patients were excluded due to an unclear time of PNES onset.
Fifty-nine patients (43 female [72.9%]; mean age of 35.12 years [SD AE 10.74]) who fulfilled the diagnostic criteria were diagnosed with PNES alone. Twelve patients were not using AEDs and were excluded from this analysis.
Methods
The PNES frequency was evaluated based on two measures: the patients' medical file, and a direct interview during video-EEG.
Seizure diaries were evaluated by the patients' doctors and were reported in the patients' medical files at the times of their medical appointments. These files were retrospectively assessed during video-EEG monitoring by the authors.
The patients and their families were directly interviewed during video-EEG monitoring. The information obtained during the interview was required to be consistent with the results of the medical chart revision. In cases of doubt, the patient and family were directly questioned. Only patients who fulfilled this criterion were included.
Patients with PNES alone were categorized, according to the response to AEDs, in two groups: responders (patients who achieved PNES remission) and no responders (patients who experienced no improvement).
Remission was considered partial (>50%) or complete based on a comparison to the baseline condition prior to AED administration. The time of remission was also documented for each patient based on the medical file revisions.
Additionally, we evaluated the diagnostic delay between the first event and the final diagnosis during the video-EEG.
Statistical analysis
First, the clinical and demographic variables were compared between the groups using Student's t-test for continuous data. The chi-square and Fisher's exact tests were used for categorical data. The level of significance was set at 5%. Five (10.6%) patients experienced complete remission, and 17 (36.2%) reported decrease in the frequency of PNES following AED administration (i.e., after the introduction and/or titration of an AED). The period of remission ranged from 2 months to 4 years (mean of 7.2 months; median of 4 months; SD AE 9.6 months).
Results
Remission of PNES
None of the patients reported increase in seizures following AED administration. Five patients who experienced partial remission also reported changes in event semiology (i.e., the seizures were less intense and shorter than usual).
Twenty-five (53.2%) patients reported no improvement due to AEDs.
The clinical characteristics of these groups were similar with the exception of the female predominance (p = 0.023) among the group that experienced PNES remission (Table 1) .
Duration of the delay to diagnosis
The duration of the diagnostic delay was 10.59 years among the AED responders (SD AE 10.10) and 5.60 years (SD AE 5.07) among the non-responders (Fig. 1) .
The mean diagnostic delay was considerably longer among the responders than the non-responder PNES patients (p = 0.035).
The patients who were receiving polytherapy reported a greater number of side effects. Six patients (6.4%) reported intoxication characterized by vertigo, drowsiness and ataxia. Nineteen (40.4%) patients (40% [10/25] among the non-responders and 40.9% [9/22] among the responders) reported side effects that warranted dose reductions or the use of another AED.
The patients who exhibited decrease in PNES did not exhibited a greater number of side effects (p = 0.956). 
Discussion
The placebo effect is a frequently observed phenomenon that has been described in different conditions. [5] [6] [7] In patients with PNES, the placebo response is characterized by a remission due to AEDs, which reinforces the diagnosis of epilepsy and is associated with important economic and social costs. 8 Therefore, the authors believe that the placebo response deserves special attention in PNES.
In this retrospective observational study, we observed that nearly 80% of the patients with PNES without epilepsy received AEDs, which reemphasizes that patients with PNES are treated as patients with refractory epilepsy. 2 In a previous work, Oto et al. 7 reported that 43% of their patients experienced improvement in PNES frequency after initiating AEDs. Our findings not only corroborate this high rate of placebo response but also show that the placebo effect in PNES is greater (43-46.8%) than those that are typically documented in other disorders (30%). [5] [6] [7] In our group, the durations of PNES remission were as long as 4 years. Some of our patients also reported changes in semiology that were similar to those that have been described by patients with epilepsy. There is evidence that patients with PNES are suggestible, 1 and this suggestibility might have contributed to an enhanced susceptibility to the placebo response among our patients. However, mood-stabilizing effects might have contributed in some cases. De Timary et al. 9 emphasized that diagnosis of epilepsy should be reconsidered for patients with seizures that do not respond to AEDs. Moreover, Davis 10 suggested that lack of response to AEDs is a major predictor of PNES prior to video-EEG. It seems reasonable to state that the placebo effect has been frequently neglected in PNES. A lack of response to AEDs remains a common-knowledge red flag for the diagnosis of PNES 4 among neurologists and psychiatrists.
In a previous study that was conducted with a large sample of 102 Brazilian patients, we documented a diagnostic delay of 7.8 years. 11 In the current study, the patients who experienced PNES remission had a mean diagnostic delay of 10.6 years, and the other patients had a mean delay of 5.6 years. These findings demonstrate the clinical effect of this placebo effect on diagnosis. One point that should be addressed is that the responders and non-responders did not differ in the majority of demographic and clinical aspects. The female predominance among the placebo group might have been incidental and due to the small sample size or due to a gender-linked difference in the effects of modeling on psychogenic symptoms as has previously been reported. 12 Multiple patient factors are associated with longer delays to diagnosis, 3 and such delays obviously cannot be explained by one single factor. AED treatment has previously been shown to be one of these factors. 3 It is possible that the response to AED treatment might have played a role in the former series. The retrospective nature of this study was a major limitation to our ability to precisely determine the PNES frequency. Therefore, most of the information obtained was based in the patients' and doctors' perceptions. Precise quantitative data were not attainable with this study design. Another issue was the small sample size of each group. A prospective study with larger sample sizes is necessary to confirm these results and to delineate the differences between these groups.
In conclusion, patients with PNES without epilepsy can exhibit a decrease in PNES frequency due to a placebo effect. A favorable response to AEDs favors the diagnosis of epilepsy and postpones the diagnosis of PNES. Thus, neurologists and psychiatrists need to be aware that this group of patients is highly vulnerable to placebo effects and thus a good response to AEDs cannot be used as an isolated sign in the diagnosis of PNES. 
